BioCryst Pharmaceuticals, Inc. (BCRX)
7.545
-0.06
(-0.85%)
USD |
NASDAQ |
Feb 25, 16:00
7.58
+0.04
(+0.46%)
After-Hours: 20:00
BioCryst Pharmaceuticals Free Cash Flow : 47.64M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| KalVista Pharmaceuticals, Inc. | -- |
| Plus Therapeutics, Inc. | -15.78M |
| BioStem Technologies, Inc. | 12.23M |
| Iovance Biotherapeutics, Inc. | -351.82M |
| Protokinetix, Inc. | -0.2226M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 41.11M |
| Cash from Investing (Quarterly) | 13.57M |
| Cash from Financing (Quarterly) | -58.30M |
| Free Cash Flow Per Share (Quarterly) | 0.1809 |
| Free Cash Flow to Equity (Quarterly) | 95.58M |
| Free Cash Flow to Firm (Quarterly) | 60.67M |
| Free Cash Flow Yield | 2.93% |